We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.
Peptone has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in June 2022.
Peptone's investors include Bessemer Venture Partners, Walden Catalyst, F-Prime, Founders Factory, Hoxton Ventures.
Peptone is headquartered in London, United Kingdom.
We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.
Peptone is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Peptone — Funding & Investors." VCBacked, June 9, 2022, https://www.vcbacked.co/company/peptone. Accessed August 14, 2026.
VCBacked. (2022). Peptone — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/peptone
{{cite web |title=Peptone — Funding & Investors |url=https://www.vcbacked.co/company/peptone |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated